Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer.

Iwaya T, Fukagawa T, Suzuki Y, Takahashi Y, Sawada G, Ishibashi M, Kurashige J, Sudo T, Tanaka F, Shibata K, Endo F, Katagiri H, Ishida K, Kume K, Nishizuka S, Iinuma H, Wakabayashi G, Mori M, Sasako M, Mimori K.

Clin Cancer Res. 2013 Dec 1;19(23):6438-49. doi: 10.1158/1078-0432.CCR-12-3186. Epub 2013 Oct 4.

2.

Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.

PMID:
22407237
3.

Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.

Yang Q, Zhang C, Huang B, Li H, Zhang R, Huang Y, Wang J.

Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7. doi: 10.1097/MEG.0b013e32835ed691.

PMID:
23751352
4.

Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases.

Akiyoshi S, Fukagawa T, Ueo H, Ishibashi M, Takahashi Y, Fabbri M, Sasako M, Maehara Y, Mimori K, Mori M.

Br J Cancer. 2012 Oct 9;107(8):1345-53. doi: 10.1038/bjc.2012.326. Epub 2012 Sep 6.

5.

MicroRNA-146a is down-regulated in gastric cancer and regulates cell proliferation and apoptosis.

Hou Z, Xie L, Yu L, Qian X, Liu B.

Med Oncol. 2012 Jun;29(2):886-92. doi: 10.1007/s12032-011-9862-7. Epub 2011 Feb 24.

PMID:
21347720
6.

A large-scale study of MT1-MMP as a marker for isolated tumor cells in peripheral blood and bone marrow in gastric cancer cases.

Mimori K, Fukagawa T, Kosaka Y, Ishikawa K, Iwatsuki M, Yokobori T, Hirasaki S, Takatsuno Y, Sakashita H, Ishii H, Sasako M, Mori M.

Ann Surg Oncol. 2008 Oct;15(10):2934-42. doi: 10.1245/s10434-008-9916-z. Epub 2008 Jul 26.

PMID:
18661187
7.

Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.

Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9.

PMID:
22322911
8.

Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.

Ota D, Mimori K, Yokobori T, Iwatsuki M, Kataoka A, Masuda N, Ishii H, Ohno S, Mori M.

Int J Oncol. 2011 Apr;38(4):955-62. doi: 10.3892/ijo.2011.926. Epub 2011 Jan 26.

PMID:
21271219
9.

[Relationship between the expression level of miR-29c and biological behavior of gastric cancer].

Ma XQ, Wang LP, Luo QC, Cai JC.

Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):325-30. doi: 10.3760/cma.j.issn.0253-3766.2013.05.002. Chinese.

PMID:
24054006
10.

Prognostic significance of osteopontin expression in human gastric carcinoma.

Higashiyama M, Ito T, Tanaka E, Shimada Y.

Ann Surg Oncol. 2007 Dec;14(12):3419-27. Epub 2007 Sep 26.

PMID:
17896150
11.

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.

Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z.

Ann Surg Oncol. 2011 Dec;18(13):3858-67. doi: 10.1245/s10434-011-1668-5. Epub 2011 Mar 26.

PMID:
21442347
12.

Inverse association between miR-194 expression and tumor invasion in gastric cancer.

Song Y, Zhao F, Wang Z, Liu Z, Chiang Y, Xu Y, Gao P, Xu H.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S509-17. doi: 10.1245/s10434-011-1999-2. Epub 2011 Aug 16.

PMID:
21845495
13.
14.

Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.

Lv H, Cui A, Sun F, Zhang Y, Li Y, Li L, Lin Z.

Exp Mol Pathol. 2014 Aug;97(1):74-80. doi: 10.1016/j.yexmp.2014.05.007. Epub 2014 May 24.

PMID:
24866365
15.

miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.

Tang H, Deng M, Tang Y, Xie X, Guo J, Kong Y, Ye F, Su Q, Xie X.

Clin Cancer Res. 2013 Oct 15;19(20):5602-12. doi: 10.1158/1078-0432.CCR-13-1326. Epub 2013 Aug 30.

16.

Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis.

Iwatsuki M, Fukagawa T, Mimori K, Nakanishi H, Ito S, Ishii H, Yokobori T, Sasako M, Baba H, Mori M.

Br J Cancer. 2009 Jun 16;100(12):1937-42. doi: 10.1038/sj.bjc.6605085. Epub 2009 Jun 2.

17.

High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.

Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, Peng JJ, Huang XH.

Ann Surg Oncol. 2009 Jan;16(1):208-19. doi: 10.1245/s10434-008-0214-6. Epub 2008 Nov 14.

PMID:
19009246
18.

Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.

Wang X, Wang J, Ma H, Zhang J, Zhou X.

Med Oncol. 2012 Jun;29(2):919-27. doi: 10.1007/s12032-011-9880-5. Epub 2011 Mar 10.

PMID:
21390519
19.

Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer.

Sun M, Jin FY, Xia R, Kong R, Li JH, Xu TP, Liu YW, Zhang EB, Liu XH, De W.

BMC Cancer. 2014 May 6;14:319. doi: 10.1186/1471-2407-14-319.

20.

Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.

Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.

Hepatogastroenterology. 2008 May-Jun;55(84):1131-5.

PMID:
18705345

Supplemental Content

Support Center